The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response this week shared resources for protecting…
Headline
The Food and Drug Administration yesterday released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration…
Headline
The Department of Health and Human Services today released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results…
Headline
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they…
Headline
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten…
Headline
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group,…